Abstract
Two techniques of potential usefulness for understanding autism have come to the surface since the book was planned. The first is the Induced Pluripotent Stem Cells (iPSC) technology. Reprogramming has been recognized as a potential tool for rescuing impaired functions but it is also a good way for modeling diseases at the cellular level. We consider the first uses of IPSC in the field of rare genetic diseases associated with autism. A second technique is optogenetics that can be considered as making possible to link spatial, temporal and functional aspects of a nerve tissue. Its usefulness in modeling brain disorders is discussed. We revisit the susceptibility gene concept. We draw finally conclusion for treatment from the etiological heterogeneity of autism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Xu X et al (2001) Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J Biol Chem 276(36):33540–33546
Wells RD (2009) Mutation spectra in fragile X syndrome induced by deletions of CGG*CCG repeats. J Biol Chem 284(12):7407–7411
Kondapalli KC et al (2013) Functional evaluation of autism-associated mutations in NHE9. Nat Commun 4:2510
Serfontein J, Nisbet RE, Howe CJ, de Vries PJ (2010) Evolution of the TSC1/TSC2-TOR signaling pathway. Sci Signal 3(128):ra49
Takahashi K, Ichisaka T, Yamanaka S (2006) Identification of genes involved in tumor-like properties of embryonic stem cells. Methods Mol Biol 329:449–458
Takahashi K, Okita K, Nakagawa M, Yamanaka S (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protocol 2(12):3081–3089
Takahashi K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4):372–376
Ellis P et al (2004) SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 26(2–4):148–165
Shields JM, Christy RJ, Yang VW (1996) Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 271(33):20009–20017
Gearhart J, Pashos EE, Prasad MK (2007) Pluripotency redux – advances in stem-cell research. New Engl J Med 357(15):1469–1472
Abdullah AI, Pollock A, Sun T (2012) The path from skin to brain: generation of functional neurons from fibroblasts. Mol Neurobiol 45(3):586–595
Chen YJ et al (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A 107(50):21818–21823
Cheng C, Sourial M, Doering LC (2012) Astrocytes and developmental plasticity in fragile X. Neural Plast 2012:197491
Eiges R et al (2007) Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1(5):568–577
Marchetto MC et al (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143(4):527–539
Marchetto MC, Winner B, Gage FH (2010) Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 19(R1):R71–R76
Liu J et al (2012) Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet 21(17):3795–3805
Jacobs S, Cheng C, Doering LC (2012) Probing astrocyte function in fragile X syndrome. Results Probl Cell Differ 54:15–31
Jacobs S, Doering LC (2010) Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci 30(12):4508–4514
Jacobs S, Nathwani M, Doering LC (2010) Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci 11:132
Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K (2011) Optogenetics in neural systems. Neuron 71(1):9–34
Haubensak W et al (2010) Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 468(7321):270–276
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Roubertoux, P.L. (2015). Epilogue: Perspectives and Caveats. In: Roubertoux, P. (eds) Organism Models of Autism Spectrum Disorders. Neuromethods, vol 100. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2250-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2250-5_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2249-9
Online ISBN: 978-1-4939-2250-5
eBook Packages: Springer Protocols